Day One Biopharmaceuticals Inc (DAWN) — Defensive Interval Ratio
Day One Biopharmaceuticals Inc (DAWN) has a Defensive Interval Ratio of 2747 days as of September 2025. Defensive assets of $425.00 Million (cash $-, short-term investments $408.30 Million, receivables $16.70 Million) cover 2747 days of daily cash needs of $154.70K/day. Check Day One Biopharmaceuticals Inc (DAWN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Day One Biopharmaceuticals Inc Defensive Interval Ratio (2021–2024)
This chart shows how Day One Biopharmaceuticals Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 2747 days, meaning defensive assets of $425.00 Million can fund 2747 days of operations without new revenue. Also explore Day One Biopharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Day One Biopharmaceuticals Inc (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for Day One Biopharmaceuticals Inc from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Day One Biopharmaceuticals Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2090 days | $420.63 Million | $201.24K/day | $- | $406.75 Million | ▲ +413 days |
| 2023 | 1677 days | $135.56 Million | $80.84K/day | $- | $135.56 Million | ▼ -3969 days |
| 2022 | 5646 days | $257.01 Million | $45.52K/day | $- | $257.01 Million | ▲ +5646 days |
| 2021 | 0 days | $0.00 | $23.72K/day | $- | $0.00 | — |